control animals but not in those immunized. Bacteriuria was present in 89% of the controls but in only 61% of the immunized group. Hematogenously challenged, immune animals sacrificed at 6 weeks did not show histological evidence of renal pathology, and only 6% had bacteriuria. Eighty-six per cent of the nonimmune controls showed both pyelonephritis and bacteriuria. The protective effect is specific because of the following. (i) Active and passive CA immunization did not prevent pyelonephritis due to Pseudomonas aeruginosa which does not produce this antigen. (ii) Passive immunization with a CA antiserum conferred protection against a P. mirabilis challenge. (iii) Passive administration of an antiserum from which CA antibodies had been differentially absorbed abolished the protective activity.
There is very limited information available on the immune response and the role of 0 antibodies in protection against urinary tract infections (1, 3, 9) . Also, because of the persistence or recurrence of urinary tract infections with a strain of the same serological type in patients with high titers of homologous 0 antibodies, the value of host immunoglobulins versus the somatic 0 antigen of such bacteria has been questioned by many investigators. Numerous enteric bacteria, including Escherichia, Enterobacter, Proteus, Serratia, Salmonella, and Shigella, share a common antigen (CA), in addition to the well known 0, H, and Vi antigens which they may have. The common antigen first described in 1962 by Kunin et al. (8) had probably escaped detection for many years because it could be demonstrated only by means of the hemagglutination and hemolysis tests and not by bacterial agglutination or precipitation procedures. Antibodies against the CA have been shown to opsonize enteric bacteria containing this antigen (4, 5) . Since phagocytosis is one of the major defense mechanisms of the host, it is conceivable that such antibodies may play a protective role in infections including pyelonephritis of man and animals. In 1968, Gorzynski and Neter (E. A. Gorzynski and E. Neter, Bacteriol. Proc., p. 86, 1968) reported that C57BL/ 6Ha black mice immunized with the CA of Escherichia coli 014 had a death rate of 47 to 57% as compared with 72 to 80% for controls when challenged with Salmonella enteritidis. Swiss white mice, which produced CA antibodies less effectively than black mice, were not protected. The protective effects of antibodies against the enterobacterial CA in experimental hematogenous and retrograde pyelonephritis of rabbits are described in this paper.
MATERIAL AND METHODS
Common antigen preparation. CA was prepared by the previously described procedures of Suzuki et al. (10) Passive transfer of CA absorbed antiserum. A 0.5-ml amount of absorbed antiserum (with 0 antibodies remaining) was injected intravenously into 10 rabbits followed by the iv administration of 5 X 107 viable P. mirabilis organisms. A 0.5-ml amount of unabsorbed serum (containing 0 + CA antibodies) was injected into nine control rabbits and the animals were likewise challenged.
Postchallenge treatment. Six weeks after hematogenous and four weeks after retrograde challenge with live bacteria, each rabbit was bled just before sacrifice. Both kidneys were removed aseptically, and urine was removed by needle puncture of the bladder for quantitative cultures.
The individual kidneys were weighed and examined grossly for abscesses. A section was cut for histopathology, and a weighed portion was then ground with Trypticase Soy Broth by using a motorized tissue homogenizer. Pour plates of the suspension were made by using Trypticase Soy Agar. The plates were incubated at 35 C for 18 to 24 hr, and the viable count was expressed per gram of kidney tissue. Representative bacterial colonies were chosen, and biochemical and drug susceptibility patterns and slide agglutination tests with homologous antiserum were used as criteria to insure identity of the organism with the original challenge strain. Thin sections of both kidneys of each rabbit were stained with hematoxylin-eosin and examined for evidence of renal pathology without knowledge by the pathologist as to identity of specimens. Table 1 summarizes results of experiments on the effect of active immunization with CA of S. typhimurium on hematogenous and retrograde challenge with P. mirabilis. It is evident that CA immunization provided significant protection against renal infection in the hematogenously challenged group. The results also clearly show differences (significant at the 99.5 % level) between the immune and nonimmune groups with respect to bacterial recovery rates from urines and kidneys as well as renal pathology. The data in Table 1 indicate that there was a difference (significant at the 95% level) between the immune and controls in the retrogradely challenged rabbits when comparing development of kidney pathology. As for the recovery of bacteria from the urine, there was no significant difference. Although immunization protected rabbits from developing renal pathology, bladder infection was found in the majority of these animals. In the hematogenously challenged animals demonstrating acute pyelonephritis histologically, the lesions were largely of the "cannonball" type. They were, for the most part, rounded discrete masses of inflammatory infiltrate. Destruction of preexisting tissue and abscess formation were a common finding. The rounded discrete nature of the lesion was suggestive of hematogenous pyelonephritis, rather than "ascending" infection.
RESULTS
Pyelitis, when present, was sometimes unilateral, but when bilateral, differences in severity, such as between the two kidneys, were frequently demonstrated. When acute inflammatory cells were present, sections of the renal parenchyma usually showed acute pyelonephritis as well.
An inconstant finding was a focal vacuolar nephropathy, the significance of which was not determined. It was frequently associated with areas of scarring. In some instances, the cell membranes of the involved tubular epithelium appeared to be calcified.
DISCUSSION
Evidence has been obtained suggesting that immunization with the enterobacterial common antigen derived from S. typhimurium protects rabbits against pyelonephritis after hematogenous and retrograde challenge with unrelated enteric bacteria containing CA.
The following lines of evidence indicate that this protective effect is specific. (i) CA immunization did not prevent pyelonephritis due to P. aeruginosa which does not produce this antigen.
(ii) Animals passively immunized with CA antiserum did not develop pyelonephritis due to P. mirabilis. (iii) Passive immunization did not prevent a P. aeruginosa pyelonephritis. (iv) Differential absorption of CA antibodies from an antiserum containing 0 + CA antibodies abolished the protective activity of the antiserum when passively administered.
Since the vaccines utilized in priming injections for immunizing the animals contained endotoxin, the nonspecific protective activity of endotoxin might be suggested as a possible explanation for our findings. In addition to the afore mentioned evidence which serves to argue against this hypothesis, it must be emphasized that a completely heterologous 0 system was employed.
There is no known cross-reaction between S. typhimurium 0 antibodies and P. mirabilis. Also, if antirough antibodies, anti-O antibodies, or nonspecific endotoxin protection were playing a role, one would have expected to observe this phenomenon with the animals challenged with P.
aeruginosa. Pseudomonas and Proteus both contain endotoxin, yet nonspecific protection was not evident in any of the controls. The protective capacity of passively transferred antibody excludes not only tolerance but also delayed hypersensitivity as the sole mechanism of protection. Since a variety of Enterobacteriaceae have not been employed as challenge microorganisms, we have not eliminated the possibility that the protective effect may be due to antibodies directed against an antigen shared by Salmonella and Proteus only, and capable of being absorbed from the serum by an ethanol-soluble fraction derived from E. coli 04.
The resistance to pyelonephritis as reported by Sanford et al. (9) was specific, acquired immunity due to circulating antibodies. This resistance was type-specific. Both early nonspecific resistance and tolerance are classically not type-specific but are shared between various species of gram-negative bacteria. In their study, significant reduction in gross renal abscesses was not observed with any of the four heterotypic strains of E. coli or with a strain of Klebsiella pneumoniae type C when injected into animals which had been previously infected with a heterologous strain of E. coli and allowed to heal. Nonspecific protection of endotoxin or antirough antibodies, or both, did not seem to play a role in protection in these studies. Furthermore, animals so injected would not be expected to develop CA antibodies to any appreciable titers. It is therefore difficult to implicate any protective activity due to CA antibodies in this study in view of the experimental design.
The frequent absence of bacteria in the urines and kidneys of the immunized groups challenged hematogenously lends support to our interpretation of contrary findings (absence of pyelonephritis but presence of bacteriuria) in the urine of animals in the experiments on retrograde pyelonephritis: serum, rather than secretory, CA antibodies neutralize infection depending on the method of bacterial seeding. We are therefore proposing that multiplication of bacteria may be markedly retarded within the blood or kidneys, or both. It remains to be determined whether there is more rapid removal of bacteria from the circulation in the immune versus nonimmune animals, thereby diminishing the bacterial inoculation to which the renal tissue is exposed. (6) . It will be interesting to learn whether cell-bound antibodies with CA specificity are found in the kidney and urinary bladder.
The finding that the 0 antigen (lipopolysaccharide) and its lipoid A component interfere with the immunogenicity of the common antigen is of probable significance here (11, 13) . Individuals with various enterobacterial infections have been shown to develop very low hemagglutinating titers to CA antibodies with the probable exception of E. coli 014 (12) . As has been experimentally documented, it is only when CA is separated from the 0 antigen that high hemagglutinating antibody titers develop (10) . In a natural infection, CA antibodies may, therefore, seldom reach levels which are protective because of the immunosuppressive action of the bacterial llpopolysaccharide.
In addition to the reported protective effects of CA antibodies, this paper further substantiates the suitability of the oxamide-feeding experimental model for studying hematogenous pyelonephritis. Oxamide forms obstructive oxalate microdeposits in the collecting tubules, thus allowing for implantation of bacteria in the kidneys. These deposits disappear soon after the oxamide diet is discontinued. The initial feeding of oxamide allows the study of the disease in an essentially normal urinary tract and the variables of surgical or traumatic damage to the urinary tract are avoided, thus mimicking human disease. This model undoubtedly lends itself well to varied manipulation in experimental pyelonephritis.
The dynamics of the CA antibody protection are being further elucidated in our laboratory with a view to shedding further light on the following: duration of protective effect and longterm effectiveness of the CA antibodies unrelated to chemotherapy; booster effects on the antibody levels with relation to protective activity; the relationship between protective effects and various infective agents containing CA; and effects of passively administered CA antibody on the course of an already established infection. Further studies may eventually lead to clinical application.
